RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
- 1 July 2004
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 21 (7) , 1079-1086
- https://doi.org/10.1023/b:pham.0000032992.75423.9b
Abstract
At high levels as seen in diabetes, glucose reacts with and forms adducts (advanced glycation end products; AGEs) on macromolecules including proteins and DNA, eliciting cellular dysfunction and...Keywords
This publication has 70 references indexed in Scilit:
- Maillard reaction products in tissue proteins: New products and new perspectivesAmino Acids, 2003
- Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic MiceThe American Journal of Pathology, 2001
- Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.Diabetes Care, 1999
- Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling PathwaysJournal of Biological Chemistry, 1999
- RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin PolypeptidesPublished by Elsevier ,1999
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.Journal of Clinical Investigation, 1996
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995
- Studies of an unusual hemoglobin in patients with diabetes mellitusBiochemical and Biophysical Research Communications, 1969